SCHEMBL23975285

SCHEMBL23975285

c1ccc(N(c2ccccc2)c2ccc3c(c2)oc2c(N(c4ccccc4)c4ccccc4)c4ccccc4c(N(c4ccccc4)c4ccccc4)c23)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.33
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 3/20 0.33
MAPT P10636 3/20 0.33
CYP3A4 P08684 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
MEN1 O00255 3/20 0.32
HPGD P15428 3/20 0.32
KMT2A Q03164 3/20 0.32
CASP7 P55210 2/20 0.32
HSD17B10 Q99714 2/20 0.32
ESR1 P03372 2/20 0.32
TP53 P04637 1/20 0.32
MAPK1 P28482 1/20 0.32
CASP1 P29466 1/20 0.32
BRCA1 P38398 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24701068 0.92 ALDH1A1 (0.36) TDP1ALDH1A1KDM4EMAPTCYP3A4
SCHEMBL23975202 0.88 KDM4E (0.35) TDP1ALDH1A1KDM4EMAPTCYP3A4
SCHEMBL15851536 0.86 KDM5A (0.36) TDP1ALDH1A1KDM4EMAPTCYP3A4
SCHEMBL19308039 0.85 MAPT (0.40) ALDH1A1KDM4EMAPTCYP3A4L3MBTL1
SCHEMBL13508052 0.84 ALDH1A1 (0.37) TDP1ALDH1A1KDM4EMAPTCYP3A4
SCHEMBL15851595 0.83 CYP1A2 (0.36) TDP1ALDH1A1KDM4EMAPTCYP3A4
SCHEMBL15851561 0.82 PLA2G2A (0.37) KDM4EMAPTCYP3A4L3MBTL1MEN1
SCHEMBL15851521 0.82 MEN1 (0.36) KDM4EMAPTCYP3A4L3MBTL1MEN1
SCHEMBL15851539 0.82 PLA2G2A (0.36) KDM4EMAPTCYP3A4L3MBTL1MEN1
SCHEMBL15851559 0.81 GABRP (0.35) KDM4EMAPTCYP3A4L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210340103-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS THEREOF DUK SAN NEOLUX CO., LTD (KR) 2021-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210340103-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS THEREOF OR51E2, SLC39A11, WEE1 TDP1 1578/4885ALDH1A1 1489/4885KDM4E 1772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.